Among 406 patients, 49.5% had T1a or T1b tumours (≤1.0 cm), 41.6% had T1c disease (>1.0 to ≤2.0 cm), and 8.9% had T2 disease (>2.0 to ≤3.0 cm); the majority of tumours (67%) were hormone-receptor-positive (HR+) [15]. Here, NR4A1 is linked to neoplasm.